Creative Planning - KYTHERA BIOPHARMACEUTICALS I ownership

Quarter-by-quarter ownership
Creative Planning ownership history of KYTHERA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q3 2015$26,000
+62.5%
350
+7.7%
0.00%
Q1 2015$16,000
+45.5%
3250.0%0.00%
Q4 2014$11,000
+57.1%
325
+62.5%
0.00%
Q3 2014$7,000
-12.5%
200
+9.9%
0.00%
Q3 2013$8,0001820.00%
Other shareholders
KYTHERA BIOPHARMACEUTICALS I shareholders Q4 2015
NameSharesValueWeighting ↓
AlpInvest Partners B.V. 33,271$1,277,0004.55%
Palo Alto Investors LP 949,959$36,450,0002.71%
Redmile Group, LLC 560,356$21,501,0002.61%
SENZAR ASSET MANAGEMENT, LLC 124,900$4,792,0001.83%
Aureus Asset Management, LLC 152,662$5,858,0001.46%
PFM Health Sciences, LP 952,715$36,556,0000.73%
REGENTATLANTIC CAPITAL LLC 176,454$6,771,0000.63%
Polar Capital LLP 519,398$19,927,0000.42%
FNY Managed Accounts LLC 2,500$95,925,0000.35%
Partner Investment Management, L.P. 36,173$1,388,0000.28%
View complete list of KYTHERA BIOPHARMACEUTICALS I shareholders